跳转至内容
Merck
CN

V001693

没食子酸丙酯

USP, 98.0-102.0%

别名:

3,4,5-三羟基苯甲酸丙酯, Tenox PG

登录 查看组织和合同定价。

选择尺寸

变更视图

关于此项目

线性分子式:
3,4,5-(HO)3C6H2CO2CH2CH2CH3
化学文摘社编号:
分子量:
212.20
EC Number:
204-498-2
UNSPSC Code:
12352200
PubChem Substance ID:
Beilstein/REAXYS Number:
1877976
MDL number:
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助


agency

USP

assay

98.0-102.0%

mp

146-149 °C (lit.)

SMILES string

CCCOC(=O)c1cc(O)c(O)c(O)c1

InChI

1S/C10H12O5/c1-2-3-15-10(14)6-4-7(11)9(13)8(12)5-6/h4-5,11-13H,2-3H2,1H3

InChI key

ZTHYODDOHIVTJV-UHFFFAOYSA-N

Preparation Note

用甘油:PBS (9:1) 配成 0.1M 的溶液


Still not finding the right product?

Explore all of our products under 没食子酸丙酯


signalword

Danger

Hazard Classifications

Acute Tox. 4 Oral - Aquatic Acute 1 - Aquatic Chronic 1 - Eye Dam. 1 - Skin Sens. 1

wgk

WGK 2

flash_point_f

368.6 °F - closed cup

flash_point_c

187 °C - closed cup

存储类别

11 - Combustible Solids

法规信息

新产品

此项目有



历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our 文件 section.

如需帮助,请联系 客户支持

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库



Lynn M Boyden et al.
The Journal of investigative dermatology, 135(6), 1540-1547 (2014-11-15)
Genetic investigation of inherited skin disorders has informed the understanding of skin self-renewal, differentiation, and barrier function. Erythrokeratodermia variabilis et progressiva (EKVP) is a rare, inherited skin disease that is characterized by transient figurate patches of erythema, localized or generalized
Liliana O Rocha et al.
PloS one, 9(4), e92189-e92189 (2014-04-18)
Bacterial antagonists used as biocontrol agents represent part of an integrated management program to reduce pesticides in the environment. Bacillus thuringiensis is considered a good alternative as a biocontrol agent for suppressing plant pathogens such as Fusarium. In this study
Amanda Psyrri et al.
Clinical cancer research : an official journal of the American Association for Cancer Research, 20(11), 3023-3032 (2014-04-05)
We sought to evaluate the correlation between tissue biomarker expression (using standardized, quantitative immunofluorescence) and clinical outcome in the E2303 trial. Sixty-three eligible patients with operable stage III/IV head and neck squamous cell cancer (HNSCC) participated in the Eastern Cooperative